PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 445.00
Bid: 430.00
Ask: 460.00
Change: 15.00 (3.49%)
Spread: 30.00 (6.977%)
Open: 445.00
High: 445.00
Low: 445.00
Prev. Close: 430.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's Dealings

9 Jan 2009 14:18

RNS Number : 4181L
BrainJuicer Group PLC
09 January 2009
 



Press Release

 9 January 2008

BrainJuicer Group PLC

('BrainJuicer' or 'the Company')

Director's Dealings

BrainJuicer Group PLC, (AIM: BJU), a leading international online market research agency, was informed on 9 January 2009 that on the same day, James Geddes, Chief Financial Officer of the Company, exercised 228,810 options over ordinary shares of 1p each in the Company ('Ordinary Shares') at a price of 11.4p per Ordinary Share, pursuant to the Company's Employee Share Option Scheme.

Following this transaction, Mr Geddes is interested in 373,325 Ordinary Shares, representing 2.9% of the total issued share capital of the Company. These shares will rank pari passu with all existing Ordinary Shares.

 Following this notification, the Company has 12,845,336 Ordinary Shares in issue.

- Ends -

 For further information, please contact:

BrainJuicer plc

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000 

James Geddes, Chief Financial Officer

www.brainjuicer.com

Canaccord Adams Limited

Mark Williams / Adria Da Breo Richards

Tel: +44 (0)20 7050 6500

www.canaccordadams.com

UK media enquiries:

Abchurch Communications

Tel: +44 (0) 20 7398 7700

Heather Salmond / Jack Ballantyne

Tel: +44 (0) 20 7398 7714

jack.ballantyne@abchurch-group.com

www.abchurch-group.com 

Notes to Editors

BrainJuicer carries out quantitative online research using innovative, bespoke software to produce insightful market research for large, multinational companies, including 15 of the world's top 100 companies (FT 500 September 2006).

BrainJuicer operates in a growing sector of the US$25bn global research market, namely quantitative online research. BrainJuicer's main competitors are large traditional market research providers who have dominated the market for off-line market research, such as AC Nielsen, Millward Brown, Research International and Taylor Nelson Sofres.

Whilst the largest traditional research companies have developed their own online capability, BrainJuicer has a number of key attributes which have contributed to it achieving rapid growth and winning contracts with prestigious clients, including:

• Research platform that delivers greater diagnostic insight. BrainJuicer has developed tools and award-winning techniques that enable it to provide a greater level of qualitative diagnostic insight into quantitative market research. These techniques enable clients to enhance their understanding of consumer preference and help them make decisions on the best way to develop their products and services.

• Speed. BrainJuicer's automated research techniques enable it to conduct complicated studies very quickly. BrainJuicer's rapid deployment and results production, even on multi-country studies, provide clients with a speed to market advantage in the development of new products and services.

• A scaleable online-only business model. Unlike the traditional research companies who maintain both on and offline data collection capabilities, BrainJuicer is able to focus on operating a scaleable online-only business model.

To date the Group has conducted projects in over 50 countries and more than 30 languages and has established offices in the UK, the Netherlands and the US.

The Group's revenues come from full service market research work, and from its online Juicy Brains Panel in the UK.

Further information on BrainJuicer can be found at www.brainjuicer.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDBLBGGGCC
Date   Source Headline
2nd Apr 20097:00 amRNSTrading on Sharemark
19th Mar 20097:00 amRNSPreliminary Results
5th Feb 200910:35 amRNSBlocklisting Interim Review and TVR
19th Jan 20097:00 amRNSPre-Close Trading Statement
13th Jan 200910:41 amRNSDirector's Dealings
9th Jan 20092:18 pmRNSDirector's Dealings
9th Dec 20087:00 amRNSExercise of Share Options
25th Nov 20087:00 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSChange of Adviser
8th Oct 20086:02 pmRNSChange of Adviser Name
5th Sep 20087:00 amRNSInterim Results
4th Aug 20081:08 pmRNSBlocklisting Interim Review
1st Jul 20087:00 amRNSPre-Close Trading Statement
16th Jun 20087:00 amRNSGlobal Expansion
21st May 20084:40 pmRNSResult of AGM
10th Mar 20087:01 amRNSFinal Results
29th Feb 20087:00 amRNSTotal Voting Rights
25th Feb 20087:01 amRNSBlock Listing
12th Feb 20087:00 amRNSNotice of Results
11th Feb 20087:01 amRNSGlobal strategy
15th Jan 20087:00 amRNSTrading update
28th Dec 20074:51 pmRNSDirectors Dealing error
28th Dec 200711:38 amRNSDirectors Dealings
30th Nov 20077:00 amRNSIssue of Equity & TVR
31st Oct 20077:01 amRNSTotal Voting Rights
12th Oct 20077:01 amRNSIssue of Equity
20th Sep 20077:02 amRNSIndustry Award Winner
14th Sep 20071:15 pmRNSDirector/PDMR Shareholding
13th Sep 20077:01 amRNSInterim Results
5th Sep 20075:44 pmRNSNon-Exec Chairman Appointment
5th Sep 20077:01 amRNSNon-Exec Chairman Appointment
4th Sep 20077:01 amRNSNotice of Results
15th Aug 20078:10 amRNSAIM 26 and NOMAD name change
11th Jun 20077:02 amRNSCreativity Test
5th Jun 20077:03 amRNSProgress - Predictive Markets
25th May 200712:45 pmRNSResult of AGM
30th Apr 20077:01 amRNSTotal Voting Rights
25th Apr 20075:41 pmRNSIssue of Equity
12th Apr 20077:01 amRNSPreliminary Results
5th Apr 20077:01 amRNSNotice of Results
19th Jan 20075:10 pmRNSDirector/PDMR Shareholding
15th Dec 200611:13 amRNSTotal Voting Rights
5th Dec 20068:00 amRNSFirst Day of Dealings on AiM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.